Continuous positive airway pressure remains the gold-standard treatment for moderate and severe OSA. A small machine delivers pressurized air through a mask, acting as a pneumatic splint to keep the airway open throughout the night. APAP (auto-adjusting PAP) titrates pressure breath by breath and is better tolerated by most new users.
First-line for moderate–severe OSA
- Highly effective at eliminating apneas when used consistently
- Reduces cardiovascular risk substantially with good adherence
- Non-surgical, reversible
Adherence remains the main challenge: ~50% of patients use it fewer than 4 hours/night at 1 year.
A custom-fitted oral appliance holds the lower jaw forward during sleep, increasing the retroglossal space and preventing tongue-base collapse. It is particularly effective in positional OSA (worse on the back) and mild-to-moderate disease with prominent lingual/hypopharyngeal obstruction.
Preferred for mild–moderate OSA or CPAP intolerance
- Silent, portable, no electricity required
- Generally better tolerated than CPAP
- Can be used as CPAP alternative in moderate OSA
Requires healthy teeth and temporomandibular joints. Dental side effects can occur with prolonged use.
Septoplasty, turbinate reduction, and functional endoscopic sinus surgery (FESS) address nasal-level obstruction. While nasal surgery is rarely curative for OSA by itself, it reliably improves CPAP adherence by lowering the pressure required to maintain airway patency, and in some mild cases it can normalize the AHI.
Adjunct or primary treatment for nasal obstruction
- Improves CPAP adherence and reduces required pressure
- Addresses nasal breathing, smell, and quality of life
- Often covered alongside other ENT procedures
Rarely sufficient as standalone therapy for moderate–severe OSA.
Uvulopalatopharyngoplasty removes and reshapes redundant soft palate, uvula, and pharyngeal tissue. Modern variations — including lateral pharyngoplasty, expansion sphincter pharyngoplasty, and palatal advancement — have improved outcomes. Success is highest when obstruction is localized to the palate-pharynx level, confirmed by DISE (drug-induced sleep endoscopy).
Selected patients with palatal obstruction
- Can achieve significant AHI reduction in well-selected cases
- Eliminates snoring in the vast majority of patients
- Permanent structural change — no nightly device required
Results are variable without DISE-guided patient selection. Not effective for multi-level obstruction alone.
A surgically implanted system (Inspire® is the best known) detects breathing effort and delivers mild electrical stimulation to the hypoglossal nerve, causing the tongue to move forward and open the airway. It is reserved for patients with moderate-to-severe OSA who cannot tolerate CPAP and have the appropriate anatomy (confirmed by DISE and BMI criteria).
Emerging option for CPAP-intolerant patients
- Highly effective in eligible candidates
- Controlled by a small remote — no mask required
- Consistent nightly use much higher than CPAP
Expensive, requires specific anatomical criteria, and involves implant surgery.
Weight loss, avoidance of alcohol close to bedtime, positional therapy (avoiding the supine position), and treatment of nasal congestion are all evidence-based measures that can meaningfully reduce AHI. In patients with mild or positional OSA and overweight, lifestyle changes may be the most impactful single intervention.
Essential complement to any treatment
- Weight loss: up to 26% AHI reduction per 10% weight lost
- Positional therapy: effective in 25–30% of OSA patients
- No cost, no device — but requires sustained commitment
Rarely sufficient alone for moderate–severe OSA, but essential alongside other therapies.